CA1301248C - Imagerie a resonance magnetique - Google Patents

Imagerie a resonance magnetique

Info

Publication number: CA1301248C
Authority: CA; Canada
Prior art keywords: radiation; sample; nuclei; frequency; pulse
Prior art date: 1987-06-23
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Expired - Lifetime

Application number

CA000570071A

Other languages

English (en)

Inventor

Ib Leunbach

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Amersham Health R&D AB

Original Assignee

Hafslund Nycomed Innovation AB

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1987-06-23

Filing date

1988-06-22

Publication date

1992-05-19

1987-06-23 Priority claimed from GB878714615A external-priority patent/GB8714615D0/en

1987-06-24 Priority claimed from GB878714814A external-priority patent/GB8714814D0/en

1988-06-22 Application filed by Hafslund Nycomed Innovation AB filed Critical Hafslund Nycomed Innovation AB

1992-05-19 Application granted granted Critical

1992-05-19 Publication of CA1301248C publication Critical patent/CA1301248C/fr

2009-05-19 Anticipated expiration legal-status Critical

Status Expired - Lifetime legal-status Critical Current

Links

238000002595 magnetic resonance imaging Methods 0.000 title abstract description 27
230000005855 radiation Effects 0.000 claims abstract description 92
230000007704 transition Effects 0.000 claims abstract description 67
230000005291 magnetic effect Effects 0.000 claims abstract description 35
230000006698 induction Effects 0.000 claims abstract description 11
238000000034 method Methods 0.000 claims description 43
239000002872 contrast media Substances 0.000 claims description 33
150000003254 radicals Chemical class 0.000 claims description 20
239000002907 paramagnetic material Substances 0.000 claims description 17
AVXURJPOCDRRFD-UHFFFAOYSA-N Hydroxylamine Chemical class ON AVXURJPOCDRRFD-UHFFFAOYSA-N 0.000 claims description 16
-1 cyclic nitroxide Chemical class 0.000 claims description 12
238000001208 nuclear magnetic resonance pulse sequence Methods 0.000 claims description 10
238000009826 distribution Methods 0.000 claims description 8
QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims description 6
229910052760 oxygen Inorganic materials 0.000 claims description 6
239000001301 oxygen Substances 0.000 claims description 6
229920006395 saturated elastomer Polymers 0.000 claims description 6
125000004432 carbon atom Chemical group C* 0.000 claims description 5
OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 4
229910052799 carbon Inorganic materials 0.000 claims description 4
NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical group [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 claims description 3
239000007788 liquid Substances 0.000 claims description 2
238000004435 EPR spectroscopy Methods 0.000 claims 7
230000001131 transforming effect Effects 0.000 claims 2
210000001519 tissue Anatomy 0.000 description 22
230000005415 magnetization Effects 0.000 description 20
238000003384 imaging method Methods 0.000 description 18
230000005298 paramagnetic effect Effects 0.000 description 18
238000001228 spectrum Methods 0.000 description 15
238000001514 detection method Methods 0.000 description 14
229910001868 water Inorganic materials 0.000 description 14
230000008878 coupling Effects 0.000 description 13
238000010168 coupling process Methods 0.000 description 13
238000005859 coupling reaction Methods 0.000 description 13
125000000217 alkyl group Chemical group 0.000 description 12
230000000694 effects Effects 0.000 description 12
239000000126 substance Substances 0.000 description 11
230000000977 initiatory effect Effects 0.000 description 10
241000894007 species Species 0.000 description 10
239000000463 material Substances 0.000 description 8
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 8
230000000875 corresponding effect Effects 0.000 description 6
230000009467 reduction Effects 0.000 description 6
125000004429 atom Chemical group 0.000 description 5
125000002887 hydroxy group Chemical group [H]O* 0.000 description 5
238000002075 inversion recovery Methods 0.000 description 5
239000002616 MRI contrast agent Substances 0.000 description 4
150000001875 compounds Chemical class 0.000 description 4
238000010438 heat treatment Methods 0.000 description 4
230000009466 transformation Effects 0.000 description 4
QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 3
125000002947 alkylene group Chemical group 0.000 description 3
125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 3
239000003795 chemical substances by application Substances 0.000 description 3
230000001419 dependent effect Effects 0.000 description 3
230000006870 function Effects 0.000 description 3
229910052739 hydrogen Inorganic materials 0.000 description 3
239000001257 hydrogen Substances 0.000 description 3
125000002768 hydroxyalkyl group Chemical group 0.000 description 3
230000006872 improvement Effects 0.000 description 3
230000000155 isotopic effect Effects 0.000 description 3
238000004519 manufacturing process Methods 0.000 description 3
238000011084 recovery Methods 0.000 description 3
229910052708 sodium Inorganic materials 0.000 description 3
239000011734 sodium Substances 0.000 description 3
230000001988 toxicity Effects 0.000 description 3
231100000419 toxicity Toxicity 0.000 description 3
IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 2
DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
241001465754 Metazoa Species 0.000 description 2
238000005481 NMR spectroscopy Methods 0.000 description 2
230000005856 abnormality Effects 0.000 description 2
230000003321 amplification Effects 0.000 description 2
238000002059 diagnostic imaging Methods 0.000 description 2
230000005281 excited state Effects 0.000 description 2
150000004676 glycans Chemical class 0.000 description 2
125000005843 halogen group Chemical group 0.000 description 2
150000002500 ions Chemical class 0.000 description 2
150000002632 lipids Chemical class 0.000 description 2
238000003199 nucleic acid amplification method Methods 0.000 description 2
229920001282 polysaccharide Polymers 0.000 description 2
239000005017 polysaccharide Substances 0.000 description 2
102000004169 proteins and genes Human genes 0.000 description 2
108090000623 proteins and genes Proteins 0.000 description 2
239000002904 solvent Substances 0.000 description 2
125000000954 2-hydroxyethyl group Chemical group [H]C([*])([H])C([H])([H])O[H] 0.000 description 1
BSFODEXXVBBYOC-UHFFFAOYSA-N 8-[4-(dimethylamino)butan-2-ylamino]quinolin-6-ol Chemical compound C1=CN=C2C(NC(CCN(C)C)C)=CC(O)=CC2=C1 BSFODEXXVBBYOC-UHFFFAOYSA-N 0.000 description 1
229920002307 Dextran Polymers 0.000 description 1
HCBIBCJNVBAKAB-UHFFFAOYSA-N Procaine hydrochloride Chemical compound Cl.CCN(CC)CCOC(=O)C1=CC=C(N)C=C1 HCBIBCJNVBAKAB-UHFFFAOYSA-N 0.000 description 1
229920002472 Starch Polymers 0.000 description 1
239000005864 Sulphur Substances 0.000 description 1
238000010521 absorption reaction Methods 0.000 description 1
125000004423 acyloxy group Chemical group 0.000 description 1
125000004450 alkenylene group Chemical group 0.000 description 1
150000001408 amides Chemical class 0.000 description 1
125000003277 amino group Chemical group 0.000 description 1
229910021529 ammonia Inorganic materials 0.000 description 1
230000009286 beneficial effect Effects 0.000 description 1
230000008901 benefit Effects 0.000 description 1
239000012620 biological material Substances 0.000 description 1
230000015572 biosynthetic process Effects 0.000 description 1
210000004369 blood Anatomy 0.000 description 1
239000008280 blood Substances 0.000 description 1
210000001124 body fluid Anatomy 0.000 description 1
239000010839 body fluid Substances 0.000 description 1
239000000872 buffer Substances 0.000 description 1
125000002837 carbocyclic group Chemical group 0.000 description 1
229920002678 cellulose Polymers 0.000 description 1
239000001913 cellulose Substances 0.000 description 1
230000008859 change Effects 0.000 description 1
125000000753 cycloalkyl group Chemical group 0.000 description 1
230000003247 decreasing effect Effects 0.000 description 1
238000012631 diagnostic technique Methods 0.000 description 1
239000003814 drug Substances 0.000 description 1
239000003995 emulsifying agent Substances 0.000 description 1
239000003623 enhancer Substances 0.000 description 1
238000011067 equilibration Methods 0.000 description 1
150000002148 esters Chemical class 0.000 description 1
125000001301 ethoxy group Chemical group [H]C([H])([H])C([H])([H])O* 0.000 description 1
230000029142 excretion Effects 0.000 description 1
230000005294 ferromagnetic effect Effects 0.000 description 1
238000009472 formulation Methods 0.000 description 1
150000002251 gadolinium compounds Chemical class 0.000 description 1
SQORATIMOBOFKR-UHFFFAOYSA-H gadolinium(3+);oxalate Chemical compound [Gd+3].[Gd+3].[O-]C(=O)C([O-])=O.[O-]C(=O)C([O-])=O.[O-]C(=O)C([O-])=O SQORATIMOBOFKR-UHFFFAOYSA-H 0.000 description 1
230000005283 ground state Effects 0.000 description 1
230000020169 heat generation Effects 0.000 description 1
125000000623 heterocyclic group Chemical group 0.000 description 1
150000002431 hydrogen Chemical class 0.000 description 1
125000004356 hydroxy functional group Chemical group O* 0.000 description 1
125000005113 hydroxyalkoxy group Chemical group 0.000 description 1
CBOIHMRHGLHBPB-UHFFFAOYSA-N hydroxymethyl Chemical compound O[CH2] CBOIHMRHGLHBPB-UHFFFAOYSA-N 0.000 description 1
238000001727 in vivo Methods 0.000 description 1
238000011503 in vivo imaging Methods 0.000 description 1
238000002347 injection Methods 0.000 description 1
239000007924 injection Substances 0.000 description 1
230000003993 interaction Effects 0.000 description 1
238000002372 labelling Methods 0.000 description 1
125000005647 linker group Chemical group 0.000 description 1
230000037353 metabolic pathway Effects 0.000 description 1
229910052751 metal Inorganic materials 0.000 description 1
239000002184 metal Substances 0.000 description 1
125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
210000003470 mitochondria Anatomy 0.000 description 1
239000000203 mixture Substances 0.000 description 1
229910052757 nitrogen Inorganic materials 0.000 description 1
238000009828 non-uniform distribution Methods 0.000 description 1
VIKNJXKGJWUCNN-XGXHKTLJSA-N norethisterone Chemical compound O=C1CC[C@@H]2[C@H]3CC[C@](C)([C@](CC4)(O)C#C)[C@@H]4[C@@H]3CCC2=C1 VIKNJXKGJWUCNN-XGXHKTLJSA-N 0.000 description 1
210000000056 organ Anatomy 0.000 description 1
230000010355 oscillation Effects 0.000 description 1
230000003647 oxidation Effects 0.000 description 1
238000007254 oxidation reaction Methods 0.000 description 1
230000010287 polarization Effects 0.000 description 1
238000011176 pooling Methods 0.000 description 1
239000002243 precursor Substances 0.000 description 1
238000002601 radiography Methods 0.000 description 1
238000009738 saturating Methods 0.000 description 1
238000012216 screening Methods 0.000 description 1
210000002966 serum Anatomy 0.000 description 1
230000002226 simultaneous effect Effects 0.000 description 1
239000000243 solution Substances 0.000 description 1
230000003595 spectral effect Effects 0.000 description 1
238000004611 spectroscopical analysis Methods 0.000 description 1
235000019698 starch Nutrition 0.000 description 1
239000008107 starch Substances 0.000 description 1
230000004936 stimulating effect Effects 0.000 description 1
230000000638 stimulation Effects 0.000 description 1
238000006467 substitution reaction Methods 0.000 description 1
238000003786 synthesis reaction Methods 0.000 description 1
230000001225 therapeutic effect Effects 0.000 description 1
238000000844 transformation Methods 0.000 description 1
210000001635 urinary tract Anatomy 0.000 description 1
210000004291 uterus Anatomy 0.000 description 1

Landscapes

Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Magnetic Resonance Imaging Apparatus (AREA)

CA000570071A 1987-06-23 1988-06-22 Imagerie a resonance magnetique Expired - Lifetime CA1301248C (fr)

Applications Claiming Priority (4)

Application Number	Priority Date	Filing Date	Title
GB8714615		1987-06-23
GB878714615A GB8714615D0 (en)	1987-06-23	1987-06-23	Apparatus
GB878714814A GB8714814D0 (en)	1987-06-24	1987-06-24	Fishing lures
GB8714814		1987-06-24

Publications (1)

Publication Number	Publication Date
CA1301248C true CA1301248C (fr)	1992-05-19

Family

ID=26292387

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
CA000570071A Expired - Lifetime CA1301248C (fr)	1987-06-23	1988-06-22	Imagerie a resonance magnetique

Country Status (1)

Country	Link
CA (1)	CA1301248C (fr)

1988
- 1988-06-22 CA CA000570071A patent/CA1301248C/fr not_active Expired - Lifetime

Legal Events

Date	Code	Title	Description
2001-05-22	MKLA	Lapsed

Publication	Publication Date	Title
EP0296833B1 (fr)	1991-09-25	L'imagerie par résonance magnétique
EP0351919B1 (fr)	1992-07-01	Milieux de contraste contenant des radicaux libres stables
EP0361551B1 (fr)	1993-11-10	Imagerie par thermographie
CA1329639C (fr)	1994-05-17	Imagerie a resonance magnetique
US5203332A (en)	1993-04-20	Magnetic resonance imaging
JPH07505638A (ja)	1995-06-22	磁気共鳴イメージングの方法および組成物
CA2050494C (fr)	1999-09-07	Methode d'imagerie a resonance magnetique
CA1301248C (fr)	1992-05-19	Imagerie a resonance magnetique
Gjesdal	1993	Two pulse sequences for nmr imaging